CV Risk Master Class - Middle East
May 24-25, Dubai UAE
Educational Alliance to Optimize CV risk management
CV Risk Master Classes: Applying new insights to clinical practice
The lectures are recorded during the CardioVascular Risk Master Class, Middle East, Eastern Europe & African chapter, held on May 24-25, 2013 in Dubai, UAE. The presentations are intended for educational support of participants to the meeting. To view and open the presentations an additional log-on with a passcode is required. This passcode is provided to meeting participants only.
Prof. John Deanfield, MD, UCL, London, United Kingdom
The challenge for CV Risk management in Middle East, Africa & Eastern Europe:
Opportunities for early intervention
Latest insights from clinical trials:
The unassailable case for LDL-c lowering & statin therapyKees Hovingh, MD, Academic Medical Centre, Amsterdam, The Netherlands
How does BP lowering prevent the clinical manifestations of CV disease?Prof. Richard Hobbs, MD, University of Oxford, United Kingdom
Macrovascular disease in diabetes: Opportunities for lipid managementProf. John Betteridge, MD, UCL, London, United Kingdom
Novel therapies for the prevention of atherosclerotic vascular diseaseProf. John Kastelein, MD, Academic Medical Centre, Amsterdam, The Netherlands
The kidney & statin therapy: Friend or Foe?Kees Hovingh, MD, Academic Medical Centre, Amsterdam,The Netherlands
Update on new CV Risk guidelines: an international perspectiveProf. John Deanfield, MD, UCL, London, United Kingdom
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.